A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study-Reference-Cited by-同舟云学术

A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Hicks David G.,Buscaglia Brandon,Goda Hideki,McMahon Loralee,Natori Takako,Turner Bradley,Soukiazian Armen,Okada Hisatake,Nakano Yasushi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5172-1.pdf

Reference44 articles.

1. Ross JS, Fletcher JA, Linette GP, et al. The her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 2003;8(4):307–25.

2. Pegram MD, Konecny G, Slamon DJ. The molecular and cellular biology of HER2/neu gene amplification/over-expression and the clinical development of Herceptin (trastuzumab) therapy for breast cancer. Cancer Treat Res. 2000;103:57–75.

3. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783–92.

4. Perez EA, Romond EH, Suman VJ, et al. Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol. 2011;29(25):3366–73.

5. Gianni L, Dafni U, Gelber RD, et al. Herceptin adjuvant (HERA) trial study team. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol. 2011;12(3):236–44.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A ratiometric electrochemical biosensor based on ARGET ATRP for detection of HER2 gene;Talanta;2024-08

2. Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray;PLOS ONE;2024-05-15

3. Recent Trends and Innovations in Bead-Based Biosensors for Cancer Detection;Sensors;2024-05-01

4. Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors;Frontiers in Immunology;2023-09-18

5. The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancer;Expert Review of Anticancer Therapy;2023-09-12